NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Hims & Hers Health
HIMS
US Stock MarketDetailed Quotes
DGX Quest Diagnostics
- 175.410
- +1.350+0.78%
Close Feb 25 16:00 ET
- 175.410
- 0.0000.00%
Post 16:43 ET
19.47BMarket Cap22.81P/E (TTM)
176.440High173.920Low1.68MVolume174.000Open174.060Pre Close294.27MTurnover1.52%Turnover Ratio22.81P/E (Static)110.98MShares176.44052wk High2.87P/B19.37BFloat Cap121.31752wk Low2.96Dividend TTM110.41MShs Float176.440Historical High1.69%Div YieldTTM1.45%Amplitude2.570Historical Low175.529Avg Price1Lot Size
Quest Diagnostics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 4.87%1.33B | -11.95%464M | 71.98%356M | -18.92%360M | 63.83%154M | -25.96%1.27B | 57.78%527M | -58.76%207M | 10.45%444M | -80.42%94M |
| Net income from continuing operations | 1.43%921M | 15.12%236M | 0.00%237M | -3.61%240M | -4.15%208M | -10.54%908M | 76.72%205M | -14.13%237M | -0.40%249M | -41.82%217M |
| Depreciation and amortization | 12.30%493M | 23.85%135M | 12.61%125M | 4.46%117M | 8.41%116M | 0.46%439M | -6.03%109M | 2.78%111M | 4.67%112M | 0.94%107M |
| Deferred tax | 126.53%13M | 440.00%34M | 165.22%15M | -50.00%-18M | -350.00%-18M | -5,000.00%-49M | 77.27%-10M | -135.38%-23M | -152.17%-12M | 90.70%-4M |
| Other non cash items | -63.41%15M | -106.90%-2M | -90.91%1M | 350.00%5M | 266.67%11M | -37.88%41M | 0.00%29M | 175.00%11M | -106.90%-2M | -25.00%3M |
| Change In working capital | -38.62%-201M | -81.03%33M | 71.62%-42M | -107.41%-6M | 26.19%-186M | -221.85%-145M | 87.10%174M | -577.42%-148M | 400.00%81M | -1,245.45%-252M |
| -Change in receivables | -373.33%-71M | -2.82%69M | 43.75%-27M | -95.00%1M | -96.55%-114M | -106.10%-15M | -15.48%71M | -500.00%-48M | -74.36%20M | -180.56%-58M |
| -Change in payables and accrued expense | 10.53%-51M | -88.51%20M | 125.00%20M | -61.22%19M | 45.00%-110M | 68.33%-57M | 1,840.00%174M | -328.57%-80M | 136.30%49M | -185.71%-200M |
| -Change in other working capital | -8.22%-79M | 21.13%-56M | -75.00%-35M | -316.67%-26M | 533.33%38M | -237.74%-73M | -473.68%-71M | -25.00%-20M | -60.00%12M | -70.00%6M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 4.87%1.33B | -11.95%464M | 71.98%356M | -18.92%360M | 63.83%154M | -25.96%1.27B | 57.78%527M | -58.76%207M | 10.45%444M | -80.42%94M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -140.15%-2.55B | -340.35%-502M | -1,426.17%-1.63B | 70.67%-200M | -34.81%-213M | -95.40%-1.06B | 34.48%-114M | 9.32%-107M | -731.71%-682M | 6.51%-158M |
| Capital expenditure reported | -4.17%-425M | -70.83%-123M | -0.95%-106M | 11.54%-92M | 18.11%-104M | -0.99%-408M | 51.02%-72M | 11.02%-105M | -36.84%-104M | -101.59%-127M |
| Net business purchase and sale | -254.17%-2.16B | ---383M | -76,550.00%-1.53B | 81.66%-106M | -358.06%-142M | -324.31%-611M | --0 | ---2M | -57,700.00%-578M | 70.48%-31M |
| Net other investing changes | 197.62%41M | --4M | --6M | ---2M | --33M | -940.00%-42M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -140.15%-2.55B | -340.35%-502M | -1,426.17%-1.63B | 70.67%-200M | -34.81%-213M | -95.40%-1.06B | 34.48%-114M | 9.32%-107M | -731.71%-682M | 6.51%-158M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 577.50%1.08B | -230.77%-170M | 2,232.53%1.77B | -292.06%-363M | -101.32%-153M | 109.24%160M | 123.85%130M | 82.49%-83M | 178.10%189M | 83.86%-76M |
| Net issuance payments of debt | 106.28%1.54B | -100.21%-1M | 4,492.86%1.85B | -194.36%-301M | --0 | 37,500.00%748M | 47,200.00%471M | ---42M | --319M | --0 |
| Net common stock issuance | 45.09%-151M | ---- | ---- | ---- | ---- | 80.47%-275M | ---- | ---- | ---- | ---- |
| Cash dividends paid | -5.41%-331M | -5.00%-84M | -5.00%-84M | -5.00%-84M | -6.76%-79M | -2.95%-314M | -6.67%-80M | -2.56%-80M | -2.56%-80M | 0.00%-74M |
| Proceeds from stock option exercised by employees | 1.39%73M | 75.00%21M | 84.62%24M | -27.27%16M | -52.00%12M | -41.46%72M | -55.56%12M | -53.57%13M | -62.07%22M | 150.00%25M |
| Net other financing activities | 29.58%-50M | 2,150.00%45M | -157.69%-15M | 108.33%6M | -218.52%-86M | 49.29%-71M | 105.71%2M | 152.00%26M | -227.27%-72M | 18.18%-27M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 577.50%1.08B | -230.77%-170M | 2,232.53%1.77B | -292.06%-363M | -101.32%-153M | 109.24%160M | 123.85%130M | 82.49%-83M | 178.10%189M | 83.86%-76M |
| Net cash flow | ||||||||||
| Beginning cash position | 117.78%686M | 434.27%764M | 115.08%271M | 170.86%474M | 117.78%686M | -63.88%315M | -79.57%143M | -84.05%126M | -75.42%175M | -63.88%315M |
| Current changes in cash | -135.04%-130M | -138.31%-208M | 2,800.00%493M | -314.29%-203M | -51.43%-212M | 166.61%371M | 241.04%543M | 118.89%17M | -162.82%-49M | 12.50%-140M |
| Effect of exchange rate changes | ---7M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| End cash Position | -19.97%549M | -19.97%549M | 434.27%764M | 115.08%271M | 170.86%474M | 117.78%686M | 117.78%686M | -79.57%143M | -84.05%126M | -75.42%175M |
| Free cash flow | 5.21%909M | -25.05%341M | 145.10%250M | -21.18%268M | 251.52%50M | -34.25%864M | 143.32%455M | -73.44%102M | 4.29%340M | -107.91%-33M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |